Patent directory · USPTO A61K / A61P
Patents matching “Almirall, S.A.”
71 pharma patents match "Almirall, S.A." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 71 pharmaceutical patents matching "Almirall, S.A." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11602515
Pharmaceutical compositions comprising dimethyl fumarate
granted -
US 11000517
Dosage and formulation
granted -
US 10759793
2-(pyrazolopyridin-3-yl)pyrimidine derivatives as JAK inhibitors
granted -
US 10588895
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 10456390
Combinations comprising MABA compounds and corticosteroids
granted -
US 10300072
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
granted -
US 10214509
Amino-substituted heterocyclic derivatives as sodium channel inhibitors
granted -
US 10173985
Aminoindazole derivatives as sodium channel inhibitors
granted -
US 10085974
Dosage and formulation
granted -
US 10034867
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 10005771
Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
granted -
US 9907807
Topical pharmaceutical compositions
granted -
US 9757383
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
granted -
US 9737520
Aclidinium for use in improving the quality of sleep in respiratory patients
granted -
US 9687478
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 9643961
Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities
granted -
US 9579316
Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activities
granted -
US 9562039
Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities
granted -
US 9549934
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
granted -
US 9518050
Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity
granted -
US 9388189
Pyrrolotriazinone derivatives as PI3K inhibitors
granted -
US 9346759
Polymorphic crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, heminapadisytlate as agonist of the β2 adrenergic receptor
granted -
US 9340547
Pyrrolotriazinone derivatives as inhibitors P13K
granted -
US 9333195
Quinuclidine derivatives and medicinal compositions containing the same
granted